Manufacturers are responding to the expanding market with innovations in consumables, integrated systems, and next-generation ...

Anticipating trends, addressing challenges, and providing solutions that enable CDMOs to adapt to market changes.

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the ...

In July 2025 Symbiosis manufactured its 1,000th sterile batch, marking over 14 years of support for biopharma clients.

Taiwan-based Bora Pharmaceuticals plans to add further sterile fill/finish capacity at its facility in Baltimore, MD. Installation of a new AST GENiSYS ® C automated vial, syringe, and cartridge line ...

New Agreement with Thermo Fisher Scientific Expands Domestic Capacity to Support Future Commercial Manufacturing of Vaxcyte's Broad-Spectrum Pneumococcal Conjugate Vaccine Candidates SAN CARLOS, Calif ...